Video

Studies on LENSAR show evidence that FLACS delivers better outcomes

Author(s):

Dr. Sri Ganesh, MBBS, MS, DNB, chairman and managing director of Nethradhama Hospital Pvt. Ltd, discusses his studies on LENSAR and shares his findings.

"The LENSAR platform is very stable, it’s user-friendly, quite accurate and I enjoy using it.”

Dr. Sri Ganesh, MBBS, MS, DNB, chairman and managing director of Nethradhama Hospital Pvt. Ltd, has been using the LENSAR phemto platform for the past several months, performing around 800 cases.

Dr. Ganesh discusses his multiple studies on the system, including comparing different astigmatic outcomes to the previous laser system he was using. In another study he compared femto-assisted cataract surgery versus just phaco, finding significant differences.

"The LENSAR platform is very stable, it’s user-friendly, quite accurate and I enjoy using it.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.